PSA: the tool you code with matters more than the code itself.
Larotrectinib for treating NTRK fusion-positive advanced solid tumours (MA review of TA630) [ID6292] Draft guidance Technology appraisal guidance 24 April 2026 Donanemab for treating mild cognitive ...